Objectives Patients are living longer with active, advanced or metastatic disease that cannot be cured, but may be managed (ie, ‘chronic cancer’). The experiences and needs within this growing group are likely to be different from those shortly after diagnosis, on active curative treatment, or in the palliative or end-of-life phase, yet are poorly defined. We described chronic cancer patient experiences and support needs in a quantitative, multicentre cross-sectional study.
Methods Patients from five district general hospitals in England completed the 75-item Chronic Cancer Experiences Questionnaire (CCEQ). Responses were described and linear regression analysis was performed to explore the associations between poorer patient experiences and clinical/sociodemographic variables.
Results In total, 416 patients with prostate cancer (28%), breast cancer (24%), gynaecological cancer (19%), colorectal/gastrointestinal cancer (17%) and renal cancer (12%) completed the CCEQ (response rate 90%). Younger patients, those who had a longer interval between primary and advanced diagnosis and those not in a relationship, had worse experiences (R2=0.098, p<0.05). Cancer-specific symptoms were common, with 80% of participants experiencing fatigue. Areas related to poorest experiences include the coordination of care, general practitioner involvement, coping with limitations, and worries and anxieties.
Conclusions Psychological burden remains high in the chronic phase of cancer, and patients experience ongoing difficulties in accessing support and services. Younger patients who have been ill for longer and those who have less social support may be particularly vulnerable, and future studies are needed to investigate the best way to meet the unique needs of this growing patient population.
- advanced cancer
- chronic cancer
- patient experiences
- support needs
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors CH and GV conceptualised and designed the study protocol. SP, AD-O and LK collected and managed the study data. FB, CH and GV designed the data analysis plan. FB cleaned the data, carried out analysis and drafted the paper. All authors contributed to review and editing of the paper, all have seen and approved the final version of the report.
Funding This work was supported by a grant from Dimbleby Cancer Care (477221). The first author was supported by a Yorkshire Cancer Research University Academic Fellowship (L389FB).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The study was approved by the Leeds Central National Health Service (NHS) Ethics Research Committee (reference: 10/H1313/28).
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement No data are available.